NVCR logo

NovoCure Limited (NVCR) Free Cash Flow

Annual FCF:

-$69.22M+$31.20M(+31.07%)
December 31, 2024

Summary

  • As of today, NVCR annual free cash flow is -$69.22 million, with the most recent change of +$31.20 million (+31.07%) on December 31, 2024.
  • During the last 3 years, NVCR annual free cash flow has fallen by -$127.81 million (-218.16%).
  • NVCR annual free cash flow is now -182.23% below its all-time high of $84.18 million, reached on December 31, 2020.

Performance

NVCR Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Quarterly FCF:

N/A
September 30, 2025

Summary

  • NVCR quarterly free cash flow is not available.

Performance

NVCR Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherNVCRcash flow metrics

TTM FCF:

N/A
September 30, 2025

Summary

  • NVCR TTM free cash flow is not available.

Performance

NVCR TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherNVCRcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

NVCR Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+31.1%--
3Y3 Years-218.2%--
5Y5 Years-529.0%--

NVCR Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-218.2%+31.1%
5Y5-Year-182.2%+31.1%
All-TimeAll-Time-182.2%+44.7%

NVCR Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$21.42M(+53.7%)
-$80.40M(-11.4%)
Mar 2025
-
-$46.28M(-273.4%)
-$72.14M(-4.2%)
Dec 2024
-$69.22M(+31.1%)
-$12.39M(-3936.8%)
-$69.22M(+11.5%)
Sep 2024
-
-$307.00K(+97.7%)
-$78.21M(+25.1%)
Jun 2024
-
-$13.17M(+69.6%)
-$104.47M(+13.6%)
Mar 2024
-
-$43.36M(-102.8%)
-$120.97M(-20.5%)
Dec 2023
-$100.43M(-1165.0%)
-$21.38M(+19.5%)
-$100.43M(-12.6%)
Sep 2023
-
-$26.57M(+10.5%)
-$89.19M(-94.3%)
Jun 2023
-
-$29.67M(-30.0%)
-$45.90M(-896.8%)
Mar 2023
-
-$22.82M(-125.0%)
-$4.61M(-148.8%)
Dec 2022
$9.43M(-83.9%)
-$10.14M(-160.6%)
$9.43M(-52.1%)
Sep 2022
-
$16.72M(+43.7%)
$19.70M(-18.2%)
Jun 2022
-
$11.63M(+232.5%)
$24.08M(-33.1%)
Mar 2022
-
-$8.78M(-6853.8%)
$36.01M(-38.5%)
Dec 2021
$58.59M(-30.4%)
$130.00K(-99.4%)
$58.59M(-44.8%)
Sep 2021
-
$21.10M(-10.4%)
$106.18M(-6.3%)
Jun 2021
-
$23.55M(+70.7%)
$113.26M(+14.3%)
Mar 2021
-
$13.80M(-71.1%)
$99.14M(+17.8%)
Dec 2020
$84.18M(+421.7%)
$47.72M(+69.3%)
$84.18M(+108.5%)
Sep 2020
-
$28.19M(+199.0%)
$40.37M(+65.6%)
Jun 2020
-
$9.43M(+916.1%)
$24.38M(+12.8%)
Mar 2020
-
-$1.16M(-129.6%)
$21.62M(+34.0%)
Dec 2019
$16.14M
$3.91M(-68.0%)
$16.14M(-40.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
$12.20M(+82.9%)
$27.25M(+40.9%)
Jun 2019
-
$6.67M(+200.4%)
$19.34M(+420.5%)
Mar 2019
-
-$6.64M(-144.2%)
$3.71M(+143.3%)
Dec 2018
-$8.58M(+78.8%)
$15.02M(+250.5%)
-$8.58M(+69.8%)
Sep 2018
-
$4.29M(+147.9%)
-$28.44M(+10.9%)
Jun 2018
-
-$8.95M(+52.7%)
-$31.93M(-6.1%)
Mar 2018
-
-$18.93M(-290.8%)
-$30.09M(+25.7%)
Dec 2017
-$40.50M(+67.7%)
-$4.84M(-709.3%)
-$40.50M(+23.3%)
Sep 2017
-
$795.00K(+111.2%)
-$52.78M(+42.6%)
Jun 2017
-
-$7.11M(+75.8%)
-$91.90M(+23.9%)
Mar 2017
-
-$29.34M(-71.4%)
-$120.79M(+3.6%)
Dec 2016
-$125.25M(-13.7%)
-$17.12M(+55.3%)
-$125.26M(+8.8%)
Sep 2016
-
-$38.32M(-6.4%)
-$137.37M(-11.0%)
Jun 2016
-
-$36.01M(-6.5%)
-$123.71M(-8.7%)
Mar 2016
-
-$33.80M(-15.6%)
-$113.85M(-3.4%)
Dec 2015
-$110.16M(-43.9%)
-$29.23M(-18.5%)
-$110.16M(-36.1%)
Sep 2015
-
-$24.67M(+5.6%)
-$80.92M(-43.9%)
Jun 2015
-
-$26.14M(+13.2%)
-$56.25M(-14.3%)
Mar 2015
-
-$30.11M(-57.8%)
-$49.20M(-24.0%)
Dec 2014
-$76.56M(-35.9%)
-
-
Jun 2014
-
-$19.08M(+7.4%)
-$39.68M(-92.6%)
Mar 2014
-
-$20.60M
-$20.60M
Dec 2013
-$56.34M
-
-

FAQ

  • What is NovoCure Limited annual free cash flow?
  • What is the all-time high annual free cash flow for NovoCure Limited?
  • What is NovoCure Limited annual free cash flow year-on-year change?
  • What is the all-time high quarterly free cash flow for NovoCure Limited?
  • What is the all-time high TTM free cash flow for NovoCure Limited?

What is NovoCure Limited annual free cash flow?

The current annual free cash flow of NVCR is -$69.22M

What is the all-time high annual free cash flow for NovoCure Limited?

NovoCure Limited all-time high annual free cash flow is $84.18M

What is NovoCure Limited annual free cash flow year-on-year change?

Over the past year, NVCR annual free cash flow has changed by +$31.20M (+31.07%)

What is the all-time high quarterly free cash flow for NovoCure Limited?

NovoCure Limited all-time high quarterly free cash flow is $47.72M

What is the all-time high TTM free cash flow for NovoCure Limited?

NovoCure Limited all-time high TTM free cash flow is $113.26M
On this page